Despite advances in the treatment of cancers through surgical procedures and new
pharmaceuticals, the treatment of hepatocellular carcinoma (HCC) remains challenging as …

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, and it
has diverse etiologies with multiple mechanisms. The diagnosis of HCC typically occurs at …

New strategies are needed to enhance the efficacy of anti–programmed cell death protein
antibody (anti–PD-1 Ab) in cancer. Here, we report that inhibiting palmitoyl-protein …

Artesunate (ART) has been indicated as a candidate drug for hepatocellular carcinoma
(HCC). Glucosylceramidase (GBA) is required for autophagic degradation. Whether ART …

Hepatocellular carcinoma (HCC) is a highly lethal malignancy characterized by poor
prognosis and a low 5-year survival rate. Drug treatment is proving to be effective in anti …

Abstract UNC-51-like kinase 1 (ULK1), as a serine/threonine kinase, is an autophagic
initiator in mammals and a homologous protein of autophagy related protein (Atg) 1 in yeast …

Autophagy is an evolutionarily conserved lysosomal-dependent pathway for degrading
cytoplasmic proteins, macromolecules, and organelles. Autophagy-related genes (Atgs) are …

Autophagy is a cellular process that removes damaged components of cells and recycles
them as biochemical building blocks. Autophagy can also be induced to protect cells in …

Transarterial radioembolization (TARE) with yttrium 90 (90 Y), an intra-arterial procedure
performed by interventional radiologists, has begun being utilized in managing …

Abstract Three viologen derivatives: 1, 1′-(4-indolyphenyl)-4, 4′-bipyridine
dihexafluorophosphate (2IV), 1, 1′-(4-phenothiazinylphenyl)-4, 4′-bipyridine …